Genomma Lab Internacional, S.A.B. de C.V. (FRA:GEKA)

Market Cap	846.91M -29.1%
Revenue (ttm)	845.22M +4.1%
Net Income	79.69M +7.0%
EPS	0.08 +0.9%
Shares Out	n/a
PE Ratio	10.63
Forward PE	8.43
Dividend	0.04 (4.41%)
Ex-Dividend Date	Dec 22, 2025

Volume	n/a
Average Volume	14
Open	0.8350
Previous Close	0.8350
Day's Range	0.8350 - 0.8350
52-Week Range	0.7600 - 1.3000
Beta	n/a
RSI	51.80
Earnings Date	Feb 25, 2026

About Genomma Lab Internacional

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, anta...

• Industry: Pharmaceutical Preparations
• Founded: 1996
• Employees: 1,708
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: GEKA

Financial Performance

In 2024, Genomma Lab Internacional's revenue was 18.61 billion, an increase of 12.99% compared to the previous year's 16.47 billion. Earnings were 2.09 billion, an increase of 92.74%.

Financial numbers in MXN